First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 167.29 USD -0.3% Market Closed
Updated: Apr 26, 2024

Abbvie Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Income from Continuing Operations Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Income from Continuing Operations
$4.9B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Income from Continuing Operations
$5.6B
CAGR 3-Years
298%
CAGR 5-Years
1%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Income from Continuing Operations
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Income from Continuing Operations
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Income from Continuing Operations
$4B
CAGR 3-Years
4%
CAGR 5-Years
11%
CAGR 10-Years
25%
Seagen Inc
NASDAQ:SGEN
Income from Continuing Operations
-$750.2m
CAGR 3-Years
N/A
CAGR 5-Years
-36%
CAGR 10-Years
-29%

See Also

What is Abbvie Inc's Income from Continuing Operations?
Income from Continuing Operations
4.9B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Income from Continuing Operations amounts to 4.9B USD.

What is Abbvie Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
2%

Over the last year, the Income from Continuing Operations growth was -59%. The average annual Income from Continuing Operations growth rates for Abbvie Inc have been 2% over the past three years , -3% over the past five years , and 2% over the past ten years .